4106 — Wellell Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual income statement for Wellell, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,374	2,664	2,647	2,387	2,404
Cost of Revenue
Gross Profit	987	1,067	1,138	1,075	1,104
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	2,270	2,479	2,465	2,255	2,254
Operating Profit	104	185	182	132	151
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	138	201	210	148	166
Provision for Income Taxes
Net Income After Taxes	104	162	153	116	122
Minority Interest
Net Income Before Extraordinary Items
Net Income	102	161	152	115	121
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	102	161	152	115	121
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.01	1.59	1.59	1.14	1.2
Dividends per Share